IDEAYA Biosciences, Inc. IDYA Proceeds From Issuance Of Warrants
Proceeds From Issuance Of Warrants at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfWarrants.
The official record: IDEAYA Biosciences, Inc.’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s proceeds from issuance of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s proceeds from issuance of warrants?
- IDEAYA Biosciences, Inc. (IDYA) reported proceeds from issuance of warrants of $0 in Q4 2025.
- What does proceeds from issuance of warrants mean?
- This represents the cash inflows received by the company from the issuance of warrants, which grant holders the right to purchase shares of common stock at a specified price. It serves as a source of capital that may be dilutive to existing shareholders upon exercise. Investors track this to evaluate the company's alternative financing strategies and potential future equity dilution.